Class III
Terminated
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
This recall has been terminated (originally issued June 26, 2013).
- Company
- Pfizer Inc
- Recall Initiated
- May 31, 2013
- Posted
- June 26, 2013
- Recall Number
- D-607-2013
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 5,410 botlles
- Firm Location
- Peapack, NJ, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Failed Dissolution Specification
Distribution
Nationwide and Puerto Rico
Lot / Code Info
Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13
More recalls by Pfizer Inc
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026